Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

View source ↗

Summary

A clinical trial investigating syndromes causing neonatal salt loss beyond congenital adrenal hyperplasia due to 21-hydroxylase deficiency is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Neonatal Salt Loss, Congenital Adrenal Hyperplasia (CAH) | Status: RECRUITING